Patrick E. Burnett M.D., Ph.D.
Net Worth

Last updated:

What is Patrick E. Burnett M.D., Ph.D. net worth?

The estimated net worth of Dr. Patrick E. Burnett M.D., Ph.D. is at least $5,352,984 as of 22 Nov 2024. He owns shares worth $2,004,148 as insider, has earned $1,489,466 from insider trading and has received compensation worth at least $1,859,370 in Arcutis Biotherapeutics, Inc..

What is the salary of Patrick E. Burnett M.D., Ph.D.?

Dr. Patrick E. Burnett M.D., Ph.D. salary is $619,790 per year as Senior Vice President & Chief Medical Officer in Arcutis Biotherapeutics, Inc..

How old is Patrick E. Burnett M.D., Ph.D.?

Dr. Patrick E. Burnett M.D., Ph.D. is 53 years old, born in 1972.

What stocks does Patrick E. Burnett M.D., Ph.D. currently own?

As insider, Dr. Patrick E. Burnett M.D., Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Arcutis Biotherapeutics, Inc. (ARQT) Senior Vice President & Chief Medical Officer 128,669 $15.58 $2,004,148

What does Arcutis Biotherapeutics, Inc. do?

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

ARQT logo
ARQT
Arcutis Biotherapeutics, Inc.
$15.58

Patrick E. Burnett M.D., Ph.D. insider trading

Arcutis Biotherapeutics, Inc.

Dr. Patrick E. Burnett M.D., Ph.D. has made 19 insider trades between 2022-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 49,952 units of ARQT stock on 29 May 2024. As of 22 Nov 2024 he still owns at least 128,669 units of ARQT stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (right to buy) 16,023 $3.64 $58,324
Option
Common Stock 16,023 N/A N/A
Sale
Common Stock 16,023 $10.14 $162,521
Sale
Common Stock 100 $10.03 $1,003
Option
Stock Option (right to buy) 100 $3.64 $364
Option
Common Stock 100 N/A N/A
Option
Stock Option (right to buy) 18,377 $3.64 $66,892
Sale
Common Stock 18,377 $10.3 $189,191
Option
Common Stock 18,377 N/A N/A
Sale
Common Stock 15,441 $8.68 $134,090
Sale
Common Stock 1,728 $8.29 $14,318
Sale
Common Stock 13,206 $9.02 $119,105
Option
Common Stock 23,000 N/A N/A
Sale
Common Stock 23,000 $8.75 $201,319
Option
Stock Option (right to buy) 23,000 $3.64 $83,720
Sale
Common Stock 49,952 $8.72 $435,382
Sale
Common Stock 9,555 $8.74 $83,492
Sale
Common Stock 4,782 $11.12 $53,181
Sale
Common Stock 1,325 $3.54 $4,692
Sale
Common Stock 300 $7.05 $2,115
Sale
Common Stock 1,305 $7.04 $9,187
Sale
Common Stock 851 $15.26 $12,989
Sale
Common Stock 23 $16.52 $380
Sale
Common Stock 1,728 $15.82 $27,334
Sale
Common Stock 1,475 $15.01 $22,137
Sale
Common Stock 30 $16.45 $493
Sale
Common Stock 981 $16.86 $16,539

Arcutis Biotherapeutics key executives

Arcutis Biotherapeutics, Inc. executives and other stock owners filed with the SEC: